Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic Review and Meta-Analysis
Metadatos
Mostrar el registro completo del ítemAutor
Calvache Mateo, Andrés; Heredia Ciuró, Alejandro; Martín-Núñez, Javier; Hernández Hernández, Sofía; López López, Laura; Valenza, Marie CarmenEditorial
MDPI
Materia
Long COVID-19 Telerehabilitation Quality of life Dyspnea Adverse effects Functional capacity
Fecha
2023-09-12Referencia bibliográfica
Calvache-Mateo, A.; Heredia-Ciuró, A.; Martín-Núñez, J.; Hernández-Hernández, S.; Reychler, G.; López-López, L.; Valenza, M.C. Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic Review and Meta-Analysis. Healthcare 2023, 11, 2519. [https://doi.org/10.3390/healthcare11182519]
Patrocinador
Spanish Ministry of Education (Grant numbers FPU: 21/00451, FPU 20/01670; FPU 19/02609; Grant numbers: EST22/00791Resumen
The aim of this review was to identify, map, and synthesize the extent and nature of
research activity on the use of telerehabilitation to support Long COVID-19 rehabilitation and
examine the efficacy and safety of respiratory telerehabilitation in patients with Long COVID-19. A
systematic review and meta-analysis of randomized controlled trials were performed. We included
controlled trials that tested the effect of respiratory telerehabilitation interventions in patients with
Long COVID-19 versus no intervention, usual care, placebo, or face-to-face intervention. The data
were pooled, and a meta-analysis was completed for quality of life, dyspnea, lung function, anxiety
and depression, respiratory muscle strength, functional capacity, and lower limb strength. Finally,
10 studies were included. The meta-analysis results show significant differences in favor of respiratory
telerehabilitation in quality of life (p = 0.02), dyspnea (p < 0.00001), respiratory muscle strength
(p < 0.001), functional capacity (p < 0.0001), and lower limb strength (p = 0.01) but not in lung function
(p = 0.28) and anxiety and depression (p = 0.55). In addition, there were no statistically significant
differences in adverse effects (p = 0.06) between the telerehabilitation and comparator groups. The
results suggest that these interventions can improve quality of life, reduce dyspnea, and increase
respiratory and lower extremity muscle strength as well as functional capacity in patients with Long
COVID-19.